View of Metronomic versus standard fixed dosing chemotherapy in human epidermal growth factor receptor-type 2-negative metastatic breast cancer: a reconstructed individual patient data meta-analysis

Return to Article Details Metronomic versus standard fixed dosing chemotherapy in human epidermal growth factor receptor-type 2-negative metastatic breast cancer: a reconstructed individual patient data meta-analysis Download Download PDF